Tibeay Biosciences B.V.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Previously recorded as Verinos Operations GmbH (to 2026)
0
Ending by 2030
Mar 2035
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 8, 2027The maintenance fee for Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions (US 11,717,522) comes due Feb 8, 2027. Unpaid by Aug 9, 2027, it lapses early.
- 1 fee due Jun 3, 2027The maintenance fee for Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions (US 10,493,075) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 8 of 8
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,016,431 | Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions In force · High confidence | In force | High confidence | |
| US 10,493,075 | Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions In force · High confidence | In force | High confidence | |
| US 10,925,877 | Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions In force · High confidence | In force | High confidence | |
| US 12,458,644 | Process for Preparing Solutions Comprising Biopterin Derivatives In force · High confidence | In force | High confidence | |
| US 9,895,372 | Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions In force · High confidence | In force | High confidence | |
| US 11,717,522 | Solid Pharmaceutical Compositions Comprising Biopterin Derivatives and Uses of Such Compositions In force · High confidence | In force | High confidence | |
| US 12,171,766 | Methods of Treating Patients Suffering from Brain Injury and Methods of Increasing the Value of the Extended Glasgow Outcome Scale of Patients Suffering from Brain Injury In force · High confidence | In force | High confidence | |
| US 12,465,609 | Methods of Treating Patients Suffering from a Disease Condition or Disorder That Is Associated with an Increased Glutamate Level In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.